Mangoceuticals, Inc. (MGRX) stock
MGRXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
$0.16−0.00 (-0.19%)
Close on Nov 17, 2026Market cap $3.45MP/E –Yield –
Mangoceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Mangoceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$3.89M. For fiscal 2025 it was -$5.85M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$5.85M | – |
| FY2024 | Dec 31, 2024 | -$4.86M | – |
| FY2023 | Dec 31, 2023 | -$7.00M | – |
| FY2022 | Dec 31, 2022 | -$1.35M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$260.51K | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.31M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.08M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.24M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.26M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.27M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.13M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.17M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.58M | – |
| Q1 FY2024 | Mar 31, 2024 | -$991.13K | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.70M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.71M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.78M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.81M | – |
| Q4 FY2022 | Dec 31, 2022 | -$649.56K | – |
| Q3 FY2022 | Sep 30, 2022 | -$600.35K | – |
| Q2 FY2022 | Jun 30, 2022 | -$77.90K | – |
| Q1 FY2022 | Mar 31, 2022 | -$18.71K | – |
See a number that looks wrong?